can tirzepatide affect your liver Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A The benefits and risks of
Description
| The employer market continues to be in a state of flux over coverage of pricey GLP-1 drugs, according to Teladoc CEO Jason Gorevic
It starts fighting for the old weight again
Run everything through the dishwasher
Exciting developments in the weight management space
In this episode of the CenExel Insights Podcast, Beth DeLuca, BS, RD, Director of Marketing and Patient Recruitment, shares how strategic patient support can strengthen retention and elevate trial performance
